Tenet Healthcare Corporation
NYSE:THC Lagerbericht
Marktkapitalisierung: US$15.7b
Tenet Healthcare Zukünftiges Wachstum
Future Kriterienprüfungen 0/6 Tenet HealthcareDer Gewinn des Unternehmens wird voraussichtlich um 38.8% pro Jahr sinken, während der Jahresumsatz voraussichtlich um 3.5% pro Jahr wachsen wird. Der Gewinn pro Aktie wird voraussichtlich sinken um 41.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 11.4% betragen.
Wichtige Informationen
-38.8%
Wachstumsrate der Gewinne
Healthcare Gewinnwachstum 20.9% Wachstumsrate der Einnahmen 3.5% Zukünftige Eigenkapitalrendite 11.4% Analystenabdeckung Good
Zuletzt aktualisiert 06 Nov 2024
Jüngste Aktualisierungen zum künftigen Wachstum
Tenet Healthcare Corporation Raises Consolidated Financial Guidance for the Full Year 2024 Oct 29
Price target increased by 12% to US$162 Jul 25
Tenet Healthcare Corporation Provides Earnings Guidance for the Third Quarter and Full Year of 2024 Jul 25
Consensus EPS estimates increase by 70% May 07
Price target increased by 9.7% to US$123 May 01
Tenet Healthcare Corporation Provides Earnings Guidance for the Second Quarter and Full Year of 2024 Apr 30
Alle Updates anzeigen
Tenet Healthcare: Targeting More Stable Demand In High-Acuity Services Nov 04
With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case Oct 30
Third quarter 2024 earnings: EPS and revenues exceed analyst expectations Oct 29
Tenet Healthcare Corporation Raises Consolidated Financial Guidance for the Full Year 2024 Oct 29 Tenet Healthcare Corporation to Report Q3, 2024 Results on Oct 29, 2024
Tenet Healthcare: Becoming A Very Healthy Business Sep 09
Insider recently sold US$1.9m worth of stock Sep 08
Earnings Working Against Tenet Healthcare Corporation's (NYSE:THC) Share Price Sep 06
Tenet Healthcare: Strong EPS Growth, But Shares Near FV (Rating Downgrade) Aug 29
Chairman & CEO recently sold US$15m worth of stock Aug 19
Chairman & CEO notifies of intention to sell stock Aug 16
Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden Aug 13
Independent Director recently sold US$2.9m worth of stock Aug 11
Independent Director notifies of intention to sell stock Aug 08
Second quarter 2024 earnings: EPS and revenues exceed analyst expectations Jul 25
Price target increased by 12% to US$162 Jul 25
Tenet Healthcare Corporation Provides Earnings Guidance for the Third Quarter and Full Year of 2024 Jul 25 Tenet Healthcare Corporation (NYSE:THC) announces an Equity Buyback for $1,500 million worth of its shares. Jul 24
An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued Jul 11
Tenet Healthcare Corporation to Report Q2, 2024 Results on Jul 24, 2024 Jun 20
Tenet Healthcare: Asset Sales, Current Multiples Support Re-Rating (Rating Upgrade) Jun 17
Lead Independent Director recently sold US$3.2m worth of stock Jun 06
Lead Independent Director notifies of intention to sell stock Jun 02
With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case May 21
Investor sentiment improves as stock rises 23% May 07
Consensus EPS estimates increase by 70% May 07
EVP, Chief Administrative Officer recently sold US$946k worth of stock May 05
EVP, Chief Administrative Officer notifies of intention to sell stock May 03
Price target increased by 9.7% to US$123 May 01
First quarter 2024 earnings: EPS and revenues exceed analyst expectations May 01
Tenet Healthcare Corporation Provides Earnings Guidance for the Second Quarter and Full Year of 2024 Apr 30
Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit Apr 30
Tenet Healthcare Corporation, Annual General Meeting, May 22, 2024 Apr 14
Tenet Healthcare Corporation, Annual General Meeting, May 22, 2024 Apr 13 Adventist Health System/West completed the acquisition of Sierra Vista Hospital, Inc and Twin Cities Community Hospital, Inc. from Tenet Healthcare Corporation (NYSE:THC).
UCI Medical Center acquired Fountain Valley Regional Hospital, Lakewood Regional Medical Center, Los Alamitos Medical, and Placentia-Linda Hospital from Tenet Healthcare Corporation (NYSE:THC). Apr 01
Tenet Healthcare Corporation to Report Q1, 2024 Results on Apr 30, 2024 Mar 29
Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet? Mar 18
Independent Director recently sold US$1.4m worth of stock Mar 17
Independent Director notifies of intention to sell stock Mar 16
Insider recently sold US$1.8m worth of stock Mar 10
Chairman & CEO exercised options and sold US$2.3m worth of stock Mar 03
Adventist Health System/West agreed to acquire Sierra Vista Hospital, Inc and Twin Cities Community Hospital, Inc. from Tenet Healthcare Corporation (NYSE:THC) for $550 million. Mar 01
Independent Director recently sold US$715k worth of stock Feb 19
New minor risk - Earnings quality Feb 18
Consensus EPS estimates increase by 144%, revenue downgraded Feb 15
Price target increased by 17% to US$104 Feb 10
Tenet Healthcare Corporation Provides Consolidated Earnings Guidance for the First Quarter and Full Year of 2024 Feb 09
Full year 2023 earnings: EPS exceeds analyst expectations Feb 08
Tenet Healthcare: Shrinking To Grow Feb 04 Novant Health, Inc. completed the acquisition of Coastal Carolina Hospital, East Cooper Medical Center and Hilton Head Hospital and Certain Related Operations in South Carolina from Tenet Healthcare Corporation (NYSE:THC) and Hilton Head Regional Healthcare, L.L.C. Feb 02
Tenet Healthcare Corporation to Report Q4, 2023 Results on Feb 08, 2024 Jan 10
Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks Dec 18
Tenet Healthcare Corporation Appoints Vineeta Agarwala to Board of Directors, Member of the Quality, Compliance, and Ethics Committee Dec 14
Independent Director recently sold US$400k worth of stock Nov 26 Novant Health, Inc. signed a definitive agreement to acquire Coastal Carolina Hospital, East Cooper Medical Center and Hilton Head Hospital and Certain Related Operations in South Carolina from Tenet Healthcare Corporation (NYSE:THC) for $2.4 billion. Nov 18
Investor sentiment improves as stock rises 18% Nov 18
We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt Nov 15
Price target decreased by 7.4% to US$84.81 Nov 01
Third quarter 2023 earnings: EPS misses analyst expectations Oct 31
Tenet Healthcare Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year 2023 Oct 31
Tenet Healthcare: A Compelling Opportunity Despite Lofty Debt Oct 13
Tenet Healthcare Corporation to Report Q3, 2023 Results on Oct 30, 2023 Oct 10 Tenet Healthcare Corporation Announces Retirement of Daniel Cancelm as Executive Vice President, Effective December 31, 2023 Tenet Healthcare Corporation Appoints Senator Roy Blunt to Board of Directors
Is Tenet Healthcare (NYSE:THC) Using Too Much Debt? Aug 02
Second quarter 2023 earnings: EPS in line with analyst expectations despite revenue beat Aug 01
Tenet Healthcare Corporation Provides Earnings Guidance for the Third Quarter and Full Year 2023 Aug 01
Tenet Healthcare: Muted Earnings Outlook Doesn't Inspire Confidence For Now Jul 28 Tenet Healthcare Corporation to Report Q2, 2023 Results on Jul 31, 2023 Jul 12
Insider notifies of intention to sell stock Jun 05
Tenet Healthcare Corporation Appoints Stephen H. Rusckowski to its Board of Directors May 31
EVP, Chief Administrative Officer recently sold US$1.5m worth of stock May 24
EVP, Chief Administrative Officer notifies of intention to sell stock May 22 Tenet Healthcare Corporation announced that it expects to receive $1.35 billion in funding May 04
Price target increased by 11% to US$82.32 Apr 29
First quarter 2023 earnings: EPS and revenues exceed analyst expectations Apr 26
Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying? Apr 13
EVP, Chief Administrative Officer recently sold US$96k worth of stock Mar 10
Independent Director notifies of intention to sell stock Mar 06
Price target increased by 7.6% to US$71.65 Feb 14
Full year 2022 earnings: Revenues and EPS in line with analyst expectations Feb 10
Tenet Healthcare Corporation Provides Earnings Guidance for the First Quarter and Full Year of 2023 Feb 10
USPI and Providence extend hands to aid ambulatory surgical services Feb 09
Now 21% undervalued Feb 03
Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden Jan 31
Gewinn- und Umsatzwachstumsprognosen NYSE:THC - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions) Datum Umsatz Gewinne Freier Cashflow Bargeld aus operativen Tätigkeiten Durchschn. Anz. Analysten 12/31/2026 22,484 1,165 1,919 2,542 15 12/31/2025 21,443 1,059 1,940 2,373 17 12/31/2024 20,795 3,149 2,735 2,012 17 9/30/2024 20,972 3,126 2,393 3,202 N/A 6/30/2024 20,916 2,755 1,891 2,660 N/A 3/31/2024 20,895 2,619 1,755 2,511 N/A 12/31/2023 20,548 611 1,623 2,374 N/A 9/30/2023 20,159 469 1,138 1,971 N/A 6/30/2023 19,894 499 961 1,783 N/A 3/31/2023 19,453 414 462 1,304 N/A 12/31/2022 19,174 410 321 1,083 N/A 9/30/2022 19,040 558 243 1,019 N/A 6/30/2022 19,133 875 414 1,136 N/A 3/31/2022 19,449 957 570 1,262 N/A 12/31/2021 19,485 915 910 1,568 N/A 9/30/2021 19,544 1,079 1,137 1,657 N/A 6/30/2021 19,207 434 1,323 1,818 N/A 3/31/2021 17,901 402 3,333 3,812 N/A 12/31/2020 17,640 399 2,867 3,407 N/A 9/30/2020 17,531 -18 2,929 3,481 N/A 6/30/2020 17,542 -48 2,685 3,307 N/A 3/31/2020 18,454 -112 692 1,352 N/A 12/31/2019 18,479 -226 563 1,233 N/A 9/30/2019 18,292 -228 258 963 N/A 6/30/2019 18,213 -10 197 882 N/A 3/31/2019 18,159 -10 280 946 N/A 12/31/2018 18,313 101 432 1,049 N/A 9/30/2018 18,672 -117 671 1,290 N/A 6/30/2018 18,769 -474 N/A 1,260 N/A 3/31/2018 19,065 -554 N/A 1,127 N/A 12/31/2017 19,179 -704 N/A 1,200 N/A 9/30/2017 19,061 -553 N/A 416 N/A 6/30/2017 19,324 -196 N/A 377 N/A 3/31/2017 19,390 -184 N/A 597 N/A 12/31/2016 19,621 -187 N/A 558 N/A 9/30/2016 19,787 -208 N/A 1,042 N/A 6/30/2016 19,630 -227 N/A 1,255 N/A 3/31/2016 19,254 -243 N/A 1,230 N/A 12/31/2015 18,634 -142 N/A 1,026 N/A 9/30/2015 18,073 19 N/A 1,054 N/A 6/30/2015 17,556 57 N/A 793 N/A 3/31/2015 17,101 107 N/A 649 N/A 12/31/2014 16,603 34 N/A 687 N/A 9/30/2014 16,023 -44 N/A 723 N/A 6/30/2014 14,256 -21 N/A 708 N/A 3/31/2014 12,641 -64 N/A 602 N/A 12/31/2013 11,087 -123 N/A 589 N/A
Mehr anzeigen
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: THCFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-38.8% pro Jahr).
Ertrag vs. Markt: THCFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-38.8% pro Jahr).
Hohe Wachstumserträge: THCFür die nächsten 3 Jahre wird mit einem Rückgang der Erträge gerechnet.
Einnahmen vs. Markt: THCDie Einnahmen des Unternehmens (3.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.9% pro Jahr).
Hohe Wachstumseinnahmen: THCDie Einnahmen des Unternehmens (3.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: THCDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (11.4%).
Wachstumsunternehmen entdecken Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
